Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

122 Results Found

Public

AHA Comments on Centers for Medicare & Medicaid Services’ Proposed Notice of Benefit and Payment Parameters for 2022

AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) proposed Notice of Benefit and Payment Parameters for 2022.
Member

CMS Issues Proposed Notice of Benefit and Payment Parameters for 2022

The Centers for Medicare & Medicaid Services (CMS) Nov.
Public

AHA to CMS Re: Short-Term, Limited-Duration Insurance

AHA comments to CMS on the proposed rule amending the definition of short-term, limited-duration health insurance.
Member

CMS Issues Final Notice of Benefit and Payment Parameters for 2021

This document provides analysis of the final rule implementing standards governing health insurance issuers and the Health Insurance Marketplaces (or “exchanges”) for 2021.
Public

AHA to CMS Re: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021

AHA comments to CMS on Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021.

Montana receives waiver to implement reinsurance program

The departments of Health and Human Services and the Treasury Friday approved a Section 1332 waiver for Montana to implement a five-year reinsurance program for its individual health insurance market beginning in 2020.

House passes legislation to lower drug prices, increase access to coverage

he House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug costs and strengthen the Affordable Care Act’s health insurance marketplaces.
Public

AHA to Rep. Frank Pallone, Jr. Re: Strengthening Health Care and Lowering Prescription Drug Costs Act

AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Public

AHA Statement Before the House Rules Committee Re: Medicare for All Act of 2019

Statement of the American Hospital Association for the Committee on Rules of the U.S. House of Representatives